Stay updated on Apatinib Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.

Latest updates to the Apatinib Plus Pembrolizumab Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedUpdated the site revision to v3.4.2 and removed the government funding status notice that accompanied v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center status was added, and the site revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedThe page now includes a glossary toggle, changes the QC update label to 'Last Update Submitted that Met QC Criteria' (from 'Last Update Submitted that met QC Criteria'), standardizes 'No FEAR Act Data' capitalization, and updates the revision footer from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check62 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check84 days agoChange DetectedIntroduces a Locations section showing Utah as a site and updates the page revision to v3.3.3. Removes the previous Utah Locations entry and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

Stay in the know with updates to Apatinib Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.